Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
32.33
-1.59 (-4.69%)
At close: Mar 20, 2026, 4:00 PM EDT
32.57
+0.24 (0.74%)
After-hours: Mar 20, 2026, 7:58 PM EDT
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $3.74 billion as of March 20, 2026. Its market cap has increased by 16.05% in one year.
Market Cap
3.74B
Enterprise Value
3.03B
1-Year Change
16.05%
Ranking
Category
Stock Price
$32.33
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $3.74B, an increase of 4,720.48%. That is a compound annual growth rate of 42.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.74B | -6.05% |
| Dec 31, 2025 | 3.98B | -11.32% |
| Dec 31, 2024 | 4.48B | 140.89% |
| Dec 29, 2023 | 1.86B | 158.22% |
| Dec 30, 2022 | 720.90M | 100.31% |
| Dec 31, 2021 | 359.90M | -12.37% |
| Dec 31, 2020 | 410.70M | -29.14% |
| Dec 31, 2019 | 579.60M | 6.02% |
| Dec 31, 2018 | 546.70M | 372.52% |
| Dec 29, 2017 | 115.70M | 382.08% |
| Dec 30, 2016 | 24.00M | -27.27% |
| Dec 31, 2015 | 33.00M | -57.42% |
| Apr 29, 2015 | 77.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CRISPR Therapeutics AG | 4.51B |
| Terns Pharmaceuticals | 4.42B |
| Ligand Pharmaceuticals | 4.20B |
| Centessa Pharmaceuticals | 3.81B |
| Crinetics Pharmaceuticals | 3.75B |
| Corcept Therapeutics | 3.63B |
| ADMA Biologics | 3.58B |
| Structure Therapeutics | 3.57B |